Cansino
- All
- News
-
Inhaled Covid Vaccine Gets Emergency Use Approval As Booster In China
China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.
-
China Approves CanSino's Inhaled Covid Vaccine For Clinical Trials
China's drug authority has approved for clinical trials an inhaled Covid-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday.
-
Pakistan To Start Importing China's CanSino Covid Vaccine For Commercial Sale
A private company in Pakistan will begin receiving shipments of China's CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the company's local partner told Reuters on Monday.
-
5 Key Takeaways From Monday's Data On Experimental Coronavirus Vaccines
Two potential vaccines to protect against the novel coronavirus - one from Oxford University and AstraZeneca Plc and the other from China's CanSino Biologics - induced immune responses in healthy volunteers without causing dangerous side effects, according to studies published on Monday in The Lancet.
-
China's Cansino In Talks For COVID-19 Vaccine Phase III Trial Overseas
Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday.
-
Cansino's COVID-19 Vaccine Candidate Approved For Military Use In China
China's military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and somewhat efficient, the company said on Monday.
-
Inhaled Covid Vaccine Gets Emergency Use Approval As Booster In China
China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.
-
China Approves CanSino's Inhaled Covid Vaccine For Clinical Trials
China's drug authority has approved for clinical trials an inhaled Covid-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday.
-
Pakistan To Start Importing China's CanSino Covid Vaccine For Commercial Sale
A private company in Pakistan will begin receiving shipments of China's CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the company's local partner told Reuters on Monday.
-
5 Key Takeaways From Monday's Data On Experimental Coronavirus Vaccines
Two potential vaccines to protect against the novel coronavirus - one from Oxford University and AstraZeneca Plc and the other from China's CanSino Biologics - induced immune responses in healthy volunteers without causing dangerous side effects, according to studies published on Monday in The Lancet.
-
China's Cansino In Talks For COVID-19 Vaccine Phase III Trial Overseas
Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday.
-
Cansino's COVID-19 Vaccine Candidate Approved For Military Use In China
China's military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and somewhat efficient, the company said on Monday.
